Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...
Patent
1981-03-27
1983-02-08
Jiles, Henry R.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Parasitic organism or component thereof or substance...
424269, 548134, 548135, 548136, 548138, 548141, 548225, 548226, 548227, 548228, 548229, 548230, 548232, 548233, 548235, 548236, 548243, 548244, 548245, 548246, 548247, 548249, 548263, 548264, 548265, 548266, 548269, 548142, A61K 3141, A61K 3142, C07D24908, C07D26108, C07D26332, C07D28510, C07D28512
Patent
active
043729630
ABSTRACT:
Bisamidines carrying one unsaturated nitrogen heterocyclo-containing substituent, representative of which i; 1-[N'-(2-(5-methyl-4-imidazolyl)methylthio)ethyl)guanidino]-8-[N'-methylgu anidino]octane, are histamine H.sub.2 -antagonists.
REFERENCES:
patent: 4034101 (1977-07-01), Durant et al.
patent: 4062967 (1977-12-01), Durant et al.
Durant Graham J.
Miles Peter D.
Foggio Richard D.
Harkaway Natalia
Jiles Henry R.
Keps Joan S.
Lourie Alan D.
LandOfFree
Oxazolyl, isoxazolyl, triazolyl and thiadiazolyl alkyl bisamidin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxazolyl, isoxazolyl, triazolyl and thiadiazolyl alkyl bisamidin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxazolyl, isoxazolyl, triazolyl and thiadiazolyl alkyl bisamidin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-49714